ACM
APLT

ACT Capital Management’s Applied Therapeutics APLT Stock Holding History

ACT Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,000
Closed -$42K – 82
2022
Q1 		$42K Hold
20,000
– – 0.04% 77
2021
Q4 		$179K Sell
20,000
-17,500
-47% -$230K 0.13% 68
2021
Q3 		$623K Hold
37,500
– – 0.32% 52
2021
Q2 		$780K Buy
+37,500
New +$710K 0.4% 47

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ACT Capital Management's APLT Position: Q2 2022 in Review

ACT Capital Management sold out of Applied Therapeutics (APLT) in Q2 2022, closing a stake of 20,000 shares — an estimated $42K sold.

ACT Capital Management first reported a position in APLT in Q2 2021 and held it in 4 quarters. The position peaked at $780K in Q2 2021. 53 funds tracked by Wall St. Rank hold APLT as of Q2 2022.

  • ACT Capital Management reported no remaining Applied Therapeutics position as of Q2 2022 after selling out during the quarter.
  • ACT Capital Management sold 20,000 Applied Therapeutics shares in Q2 2022, an estimated $42K.
  • ACT Capital Management first reported a position in Applied Therapeutics in Q2 2021 and held it in 4 quarters.
  • ACT Capital Management's Applied Therapeutics position peaked at $780K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2022.

Based on ACT Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.